Renal drug dosing by creatinine clearance
Many medications are cleared by the kidneys, so reduced renal function raises the risk of accumulation and toxicity. Renal dose adjustment uses creatinine clearance (CrCl) bands to either lower the dose or extend the dosing interval. This selector maps a patient CrCl onto common published thresholds for a curated set of antibiotics, anticoagulants, and antivirals.
How it works
Each drug carries a small table of CrCl bands. The tool finds the band that contains the entered CrCl and returns the matching recommendation. For example, many drugs follow a pattern such as: CrCl above 50 mL/min = standard dose, 30 to 50 = reduced dose or extended interval, 10 to 30 = further reduction, and below 10 = avoid or specialist dosing only.
if CrCl >= threshold_high -> standard dose
elif CrCl >= threshold_mid -> reduced dose / extended interval
elif CrCl >= threshold_low -> further reduction
else -> avoid / specialist onlyWhy CrCl bands vary by drug class
The specific thresholds and type of adjustment (dose reduction versus interval extension) depend on the pharmacokinetic properties of each drug. Understanding the logic helps clinicians apply adjustments correctly rather than just reading a table.
Time-dependent vs concentration-dependent antibiotics
For time-dependent antibiotics — those where efficacy depends on the time the drug concentration stays above the minimum inhibitory concentration (MIC), such as beta-lactam antibiotics — extending the dosing interval is often appropriate in renal impairment. This preserves the peak concentration (which drives efficacy) while reducing total exposure and the risk of accumulation.
For concentration-dependent antibiotics — those where efficacy is driven by the peak-to-MIC ratio, such as aminoglycosides — reducing the dose and maintaining the interval (or using extended-interval dosing with therapeutic drug monitoring) is the usual approach. For aminoglycosides in particular, this is further complicated by nephrotoxicity risk, which requires monitoring serum levels.
Anticoagulants
Renally cleared anticoagulants like low-molecular-weight heparins (LMWH) and direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and edoxaban accumulate in renal impairment, raising bleeding risk. Dose reductions are required at thresholds that vary by agent and indication. Many DOAC prescribing tools use the Cockcroft-Gault CrCl because the pivotal trials were conducted using that measure.
Antivirals
Several antivirals — aciclovir, valaciclovir, oseltamivir, and many others — are primarily renally excreted and require dose or interval adjustment even in moderate impairment. Failure to adjust aciclovir doses in renal impairment can cause neurological toxicity (tremor, confusion, encephalopathy).
Why Cockcroft-Gault, not eGFR?
Most renal dosing references and drug labels use Cockcroft-Gault CrCl rather than CKD-EPI or MDRD eGFR. The reason is historical and pragmatic: drug companies conducted their dose-finding and dose-adjustment studies when Cockcroft-Gault was the predominant method, so the thresholds in labels and references correspond to Cockcroft-Gault CrCl values. Using eGFR can produce slightly different numbers, and for drugs with narrow dosing windows, the difference can be clinically relevant.
For obese patients, most references recommend using ideal or adjusted body weight in the Cockcroft-Gault equation rather than actual body weight, to avoid overestimating renal clearance.
Illustrative examples
For a hypothetical drug with standard thresholds (not a specific drug recommendation):
| CrCl band (mL/min) | Typical adjustment |
|---|---|
| Greater than 50 | Standard dose |
| 30–50 | Reduce dose by approximately one third, or extend interval |
| 10–30 | Further reduction or extended interval; monitoring warranted |
| Less than 10 / dialysis | Avoid or specialist guidance; consult renal pharmacist |
Real thresholds differ by drug. Confirm against the current SmPC or BNF for the specific drug and patient before prescribing.
Scope and limitations
This tool is a teaching aid and quick reference, not a prescribing tool. It covers a curated selection of commonly adjusted drugs. It does not:
- Provide guidance for haemodialysis, peritoneal dialysis, or continuous renal replacement therapy (CRRT), which require drug-specific dosing relative to dialysis timing and clearance by the membrane
- Cover paediatric patients
- Account for hepatic impairment, which may independently affect drug clearance
- Reflect very recent label changes or locally negotiated protocols
Always confirm the specific dose against the current SmPC, BNF (for the UK), the Renal Drug Handbook, or your institutional renal dosing protocol before prescribing.
Tips and cautions
These bands are deliberately simplified for fast bedside teaching and must be confirmed against the current SmPC, BNF, or local protocol before prescribing. Use Cockcroft-Gault CrCl rather than eGFR for consistency with the source references. The tool does not cover dialysis, CRRT, or paediatric dosing, all of which require dedicated references.